S
Shandong Weigao Orthopaedic Device Co Ltd
SSE:688161
Shandong Weigao Orthopaedic Device Co Ltd
SSE:688161
Price:
30.63
CNY
-1.83%
Market Closed
Market Cap:
¥12.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shandong Weigao Orthopaedic Device Co Ltd
SSE:688161
|
CN |
|
G
|
Greatland Gold PLC
ASX:GGP
|
AU |
|
I
|
Inbest Prime III Inmuebles SOCIMI SA
MAD:YINB3
|
ES |
|
B
|
Bank of XiAn Co Ltd
SSE:600928
|
CN |
|
Granite Point Mortgage Trust Inc
NYSE:GPMT
|
US |
|
Adient PLC
NYSE:ADNT
|
IE |
|
A
|
Accsys Technologies PLC
LSE:AXS
|
UK |
|
I-Net Corp
TSE:9600
|
JP |
|
Reliance Capital Ltd
NSE:RELCAPITAL
|
IN |
|
T
|
TAAT Global Alternatives Inc
CNSX:TAAT
|
CA |
|
Zhong Yang Technology Co Ltd
TWSE:6668
|
TW |
|
C
|
Cadu Inmobiliaria SA de CV
BMV:CADUA
|
MX |
|
Chewy Inc
NYSE:CHWY
|
US |
|
Huber+Suhner AG
LSE:0QNH
|
CH |
|
H
|
Hoang Anh Gia Lai Agricultural JSC
VN:HNG
|
VN |
|
Jensen Group NV
LSE:0EX6
|
BE |
|
Oriental Land Co Ltd
TSE:4661
|
JP |
Income Statement
Earnings Waterfall
Shandong Weigao Orthopaedic Device Co Ltd
Shandong Weigao Orthopaedic Device Co Ltd
Income Statement
Shandong Weigao Orthopaedic Device Co Ltd
Shandong Weigao Orthopaedic Device Co Ltd
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
0
|
|
| Revenue |
1 824
N/A
|
1 958
+7%
|
2 087
+7%
|
2 133
+2%
|
2 154
+1%
|
2 072
-4%
|
2 163
+4%
|
1 976
-9%
|
1 848
-6%
|
1 898
+3%
|
1 548
-18%
|
1 538
-1%
|
1 284
-17%
|
1 242
-3%
|
1 229
-1%
|
1 284
+5%
|
1 453
+13%
|
1 395
-4%
|
1 443
+3%
|
|
| Gross Profit | ||||||||||||||||||||
| Cost of Revenue |
(339)
|
(365)
|
(394)
|
(408)
|
(409)
|
(426)
|
(481)
|
(467)
|
(474)
|
(525)
|
(480)
|
(516)
|
(460)
|
(485)
|
(483)
|
(483)
|
(538)
|
(481)
|
(497)
|
|
| Gross Profit |
1 485
N/A
|
1 593
+7%
|
1 693
+6%
|
1 725
+2%
|
1 744
+1%
|
1 647
-6%
|
1 682
+2%
|
1 509
-10%
|
1 374
-9%
|
1 373
0%
|
1 068
-22%
|
1 022
-4%
|
823
-19%
|
756
-8%
|
745
-1%
|
801
+8%
|
915
+14%
|
914
0%
|
946
+4%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(829)
|
(881)
|
(919)
|
(956)
|
(975)
|
(903)
|
(914)
|
(848)
|
(801)
|
(807)
|
(818)
|
(801)
|
(746)
|
(742)
|
(686)
|
(660)
|
(693)
|
(658)
|
(654)
|
|
| Selling, General & Administrative |
(748)
|
(789)
|
(818)
|
(861)
|
(856)
|
(800)
|
(799)
|
(733)
|
(692)
|
(700)
|
(675)
|
(658)
|
(611)
|
(586)
|
(561)
|
(533)
|
(568)
|
(519)
|
(504)
|
|
| Research & Development |
(78)
|
(87)
|
(97)
|
(102)
|
(116)
|
(115)
|
(126)
|
(123)
|
(99)
|
(116)
|
(114)
|
(111)
|
(119)
|
(132)
|
(132)
|
(135)
|
(109)
|
(119)
|
(114)
|
|
| Depreciation & Amortization |
(11)
|
(7)
|
(8)
|
0
|
(18)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(25)
|
0
|
0
|
0
|
(26)
|
0
|
0
|
|
| Other Operating Expenses |
8
|
1
|
4
|
6
|
15
|
11
|
11
|
7
|
13
|
9
|
(30)
|
(32)
|
8
|
(24)
|
7
|
8
|
11
|
(20)
|
(35)
|
|
| Operating Income |
656
N/A
|
712
+9%
|
774
+9%
|
768
-1%
|
770
+0%
|
743
-3%
|
768
+3%
|
661
-14%
|
573
-13%
|
567
-1%
|
250
-56%
|
221
-12%
|
77
-65%
|
14
-81%
|
59
+316%
|
141
+138%
|
222
+58%
|
256
+15%
|
292
+14%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
13
|
11
|
13
|
24
|
42
|
52
|
69
|
75
|
68
|
68
|
56
|
49
|
55
|
48
|
50
|
48
|
43
|
44
|
42
|
|
| Non-Reccuring Items |
(2)
|
(0)
|
(1)
|
2
|
0
|
(0)
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
(0)
|
6
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
|
| Total Other Income |
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
666
N/A
|
722
+8%
|
786
+9%
|
793
+1%
|
810
+2%
|
794
-2%
|
835
+5%
|
734
-12%
|
638
-13%
|
634
-1%
|
306
-52%
|
270
-12%
|
132
-51%
|
63
-52%
|
109
+73%
|
189
+73%
|
271
+44%
|
298
+10%
|
334
+12%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
(104)
|
(105)
|
(124)
|
(121)
|
(119)
|
(116)
|
(116)
|
(97)
|
(95)
|
(94)
|
(49)
|
(46)
|
(19)
|
(8)
|
(11)
|
(29)
|
(43)
|
(53)
|
(57)
|
|
| Income from Continuing Operations |
562
|
618
|
663
|
672
|
691
|
678
|
719
|
637
|
544
|
540
|
258
|
224
|
113
|
55
|
98
|
160
|
228
|
245
|
277
|
|
| Income to Minority Interest |
(3)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
0
|
1
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(4)
|
(5)
|
(5)
|
(4)
|
(4)
|
|
| Net Income (Common) |
558
N/A
|
614
+10%
|
660
+7%
|
670
+1%
|
690
+3%
|
677
-2%
|
719
+6%
|
638
-11%
|
544
-15%
|
540
-1%
|
258
-52%
|
224
-13%
|
112
-50%
|
53
-53%
|
94
+76%
|
155
+65%
|
224
+45%
|
241
+8%
|
273
+13%
|
|
| EPS (Diluted) |
1.4
N/A
|
1.54
+10%
|
1.65
+7%
|
1.67
+1%
|
1.73
+4%
|
1.69
-2%
|
1.8
+7%
|
1.6
-11%
|
1.36
-15%
|
1.35
-1%
|
0.65
-52%
|
0.56
-14%
|
0.28
-50%
|
0.13
-54%
|
0.23
+77%
|
0.39
+70%
|
0.56
+44%
|
0.6
+7%
|
0.68
+13%
|
|
Switch to:
Switch to:
See Also
Discover More
